Velocys and Morimatsu Join Forces to Accelerate Delivery of Proven Fischer-Tropsch Systems
HOUSTON and OXFORD, England, Sept. 2, 2025 /PRNewswire/ — Velocys, a leader in Fischer-Tropsch (FT) technology for the production of sustainable aviation fuel... Read more.
CENTEGIX Safety Platform® Selected by Moore Public Schools to Champion Alyssa’s Law and Protect Students, Staff, and Visitors
ATLANTA, Sept. 2, 2025 /PRNewswire/ — CENTEGIX® is honored to announce that Moore Public Schools (OK) has chosen to implement the full CENTEGIX Safety Platform®,... Read more.
Breakthrough Cancer Therapies Fuel Regulatory Momentum as Global Market Expands
Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Sept. 2, 2025 /PRNewswire/ — Cancer innovation is reaching new heights... Read more.
Evommune Announces Late-Breaker Presentation of Phase 2 Data for EVO756 in Chronic Inducible Urticaria at Upcoming European Academy of Dermatology and Venereology (EADV) 2025 Congress
–Company to host a webcast to review the full data set from Phase 2 trial — PALO ALTO, Calif., Sept. 2, 2025 /PRNewswire/ — Evommune, Inc., a... Read more.
CHRIS FAY, PRESIDENT OF TPM, LAUNCHES NEW PODCAST – BUILT WITH PURPOSE
GREENVILLE, S.C., Sept. 2, 2025 /PRNewswire/ — A new voice is rising from the foundations of industry. Built With Purpose, a thought-provoking podcast dedicated... Read more.
Beyond the Bedside: How Remote IT Access Has Become a Lifesaving Tool in Hospitals Amid Staffing Crisis
WEST HARTFORD, Conn., Sept. 2, 2025 /PRNewswire/ — As American hospitals continue to grapple with an increasing shortage of specialized medical imaging technologists,... Read more.
Homecare Homebase Announces 2025 September Gold Standard Award Winner
DALLAS, Sept. 2, 2025 /PRNewswire/ — Homecare HomebaseSM (HCHB), the leading software provider for home-based care, today announced Yetagesu (Yeta) Hurisa,... Read more.
Oncolytics Biotech® Provides Updated Clinical Safety Data for Pelareorep, Including Across Multiple Gastrointestinal Tumors
Data continue to demonstrate a favorable safety profile for pelareorep across multiple indications and in combination with multiple treatments Updated clinical data... Read more.
Identity Crime Becomes Foundation for Ongoing Schemes Targeting Life Insurance, Healthcare, Vehicle Financing and Cargo
Fraud Involving Identity Crime Expected to Rise 49% in 2025 OAK BROOK, Ill., Sept. 2, 2025 /PRNewswire/ — The ease of managing everything from ordering food... Read more.
Elevation Point Announces Strategic Collaboration with Goldman Sachs to Help Elite Partner Firms Thrive in Independence
The collaboration spans custody, asset management, lending, trading, and capital markets, enabling Elevation Point to deliver differentiated solutions tailored... Read more.